These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6231802)

  • 1. Cell-mediated immunity in seronegative spondarthritis treated with levamisole in a double-blind placebo-controlled study.
    Christensen KD; Johnsen HE; Petersen CM
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):391-5. PubMed ID: 6231802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P; Rossetti A; Valente G; Butturini U
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract]   [Full Text] [Related]  

  • 3. Levamisole and cellular immunity in rheumatoid arthritis--clinical and laboratory correlates.
    Levy J
    J Rheumatol Suppl; 1978; 4():63-70. PubMed ID: 366145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
    Froebel K; Sturrock RD; Dick WC; MacSween RN
    Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M; Trabert U; Müller W
    Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CFUC suppressor T cells in vitro. II. Effect of PHA, PWM, and Con-A on bone marrow and peripheral blood lymphocytes from healthy donors.
    Podesta M; Frassoni F; van Lint MT; Piaggio G; Marmont A; Bacigalupo A
    Exp Hematol; 1982 Mar; 10(3):256-62. PubMed ID: 6461560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M
    J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor T cell activity in splenectomized subjects.
    Melamed I; Zakuth V; Tzechoval E; Spirer Z
    J Clin Lab Immunol; 1982 Apr; 7(3):173-7. PubMed ID: 6212682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-lymphocyte reactivity and the clinical condition of patients with ankylosing spondylitis].
    Sadowska-Wróblewska M; Ryzewska A; Abgarowicz-Miłkowska T; Filipowicz-Sosnowska A; Garwolińska H; Górecka M; Kania A; Miaczyńska-Rusiniak B; Wierzchowska E
    Reumatologia; 1981; 19(2):159-67. PubMed ID: 6976607
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
    Hersey P; Ho K; Werkmeister J; Abele U
    Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of spondylitis ankylopoetica with levamisole. Behavior of clinical and immunological parameters].
    Ebner W; Senautka G
    Fortschr Med; 1983 Mar; 101(9):364-8. PubMed ID: 6852756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results.
    Feldmann JL; Mery C; Amor B; Kahan A; de Gery A; Delbarre F
    Scand J Rheumatol; 1981; 10(1):1-8. PubMed ID: 7013056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes.
    Glassman AB; Lindsay JH; Bennett CE; Hodges ER
    Ann Clin Lab Sci; 1981; 11(1):9-14. PubMed ID: 7011167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S; Sulima D; Strzelecka G
    Proc Eur Dial Transplant Assoc; 1983; 19():800-3. PubMed ID: 6603617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro lymphocyte immunoreactivity in sarcoidosis patients. Stimulation with Kveim antigens].
    Tartaglino B; Albera C; Vietti Ramus G; Cesano L
    Arch Sci Med (Torino); 1982; 139(2):183-6. PubMed ID: 7138284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
    Clegg DO; Reda DJ; Abdellatif M
    Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective migration of T-cell subset in pleural fluid from non-Hodgkin's lymphoma.
    Gupta S
    Thymus; 1981 Feb; 2(4-5):277-80. PubMed ID: 7015585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levamisole on immune function and reproductive performance in first-litter gilts.
    Purswell BJ; Dawe DL; Brown J; Williams DJ
    Am J Vet Res; 1988 Jun; 49(6):856-9. PubMed ID: 3400922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.